JLHL279.00

Jupiter Life Line Hospitals Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSHCGMARKSANSMETROPOLISPARKHOSPSCORONAMcap ₹1,829 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation42.457.087.6
+ Impairment Loss / (Reversal)0.02.90.0
+ Finance Costs26.310.632.7
+ Interest Income-19.4-19.8-29.4
+ Dividend Income-0.0-0.0-0.0
+ Fair Value (Gains) / Losses0.0-1.91.9
+ Other Non-cash Items0.41.42.0
+ Other — Cash Effects are Investing / Financing0.0-4.50.2
Changes in Working Capital
+ Inventories-2.3-2.8-11.9
+ Trade Receivables — Current-13.71.9-34.4
+ Trade Receivables — Non-current0.012.00.0
+ Other Financial Assets — Non-current-51.54.20.0
+ Other Current Assets-3.50.00.0
+ Other Non-current Assets0.00.0-6.5
+ Trade Payables — Current-8.57.426.8
+ Other Financial Liabilities — Current0.00.06.5
+ Other Current Liabilities-1.30.0-1.9
+ Other Non-current Liabilities0.0-0.80.0
+ Provisions — Current0.00.0-13.2
+ Provisions — Non-current0.00.05.9
Cash from Operating Activities
Profit Before Tax (per I/S)195.4257.7265.3247.7
+ Total Adjustments (incl. Working Capital)-31.263.066.2
Cash from Operations (pre-tax)164.2320.7331.6
+ Income Taxes Paid49.767.463.9
Cash from Operating Activities114.5253.3267.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)85.3320.7501.8
+ Disp of Fixed Assets0.10.40.0
+ Disp of Investment Property0.00.00.3
+ Acq of Other Long-term Assets25.50.00.0
+ Disp of Other Long-term Assets9.988.80.0
+ Investment in Partnership Firms / LLPs0.00.0-5.9
+ Share of Profits — Partnership Firms / LLPs1.33.10.0
+ Dividends Received — Investing0.00.00.0
+ Interest Received — Investing23.519.823.5
+ Other Inflows / (Outflows) — Investing0.00.030.2
Cash from Investing Activities-75.9-208.6-441.9
Cash from Financing Activities
+ Proceeds from Issue of Shares632.60.00.0
+ Proceeds from Borrowings83.9325.7186.0
+ Repayment of Borrowings556.40.03.3
+ Payment of Lease Liabilities0.010.916.2
+ Interest Paid26.37.623.5
+ Dividends Paid5.76.66.6
Cash from Financing Activities128.2300.6136.5
Net Changes in Cash (pre-FX)166.8345.3-37.8
Net Changes in Cash166.8345.3-37.8
Closing Cash301.354.8
Reference Items
EBITDA238.2296.6343.3344.1
EBITDA Margin %22.2723.5122.8922.09
Free Cash Flow (CFO − Capex)29.2-67.4-234.1-234.1
Free Cash Flow to Equity250.7-74.9
Free Cash Flow per Basic Share4.46-10.28-35.71-35.71
Cash Flow to Net Income0.651.311.34
Cash Paid for Taxes49.767.463.9
Cash Paid for Interest26.37.623.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.